Selective contrast-enhanced computed tomography is appropriate in diffuse large B-cell lymphoma therapy response assessment.

Katharina KriegsmannMaurizio WackMark KriegsmannMartin CremerThomas BrucknerAnthony D HoPatrick WuchterMathias Witzens-Harig

Published in: European journal of haematology (2018)

Our retrospective analysis provides a rationale for selective imaging of initially involved DLBCL sites for therapy response assessment.

Keyphrases